Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	18.68B
Revenue (ttm)	10.50B
Net Income (ttm)	861.74M
Shares Out	1.15B
EPS (ttm)	0.75
PE Ratio	21.82
Forward PE	13.02
Dividend	0.35 (2.14%)
Ex-Dividend Date	Sep 17, 2025

Volume	7,497,307
Average Volume	5,902,506
Open	16.25
Previous Close	16.27
Day's Range	16.11 - 16.32
52-Week Range	12.96 - 17.66
Beta	0.34
RSI	50.84
Earnings Date	Mar 20, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. It operates through API, CDMO, and Pharmaceutical segments. The company offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 7,060
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2024, SHE:000739's revenue was 12.02 billion, an increase of 4.77% compared to the previous year's 11.47 billion. Earnings were 1.03 billion, a decrease of -2.29%.